Scienture discloses going-concern doubt despite 449% revenue jump from product launch

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 12, 2025 · ~1 min read

Key Changes

• high

  Management disclosed substantial doubt about ability to continue as a going concern, citing $84M accumulated deficit, $3.5M cash (down 47% from year-end), and need for additional capital to fund operations.

  MD&A: Going Concern verify on EDGAR →
• high

  Q1 2026 revenue surged 449% to $56K from $10K year-ago, driven by SCN-102 (ARBLI™) wholesale distribution ramp following commercial launch; gross profit improved to $54K from $673.

  MD&A: Revenue and Gross Profit verify on EDGAR →
• high

  Net loss widened 11% to $3.4M from $3.1M year-ago, as higher professional fees (+126%) and R&D spending (+38%) offset improved gross margin and 94% reduction in interest expense.

  MD&A: Net Loss verify on EDGAR →